High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy

Ahmed M.Abu El-Asrar, Mohd Imtiaz Nawaz, Dustan Kangave, Karel Geboes, Mohammad Shamsul Ola, Saif Ahmad, Mohamed Al-Shabrawey

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Purpose: To measure levels of high-mobility group box -1 (HMGB1) and soluble receptor for advanced glycation end products (sRAGE) in the vitreous fluid from patients with proliferative diabetic retinopathy (PDR) and to correlate their levels with clinical disease activity and the levels of the inflammatory biomarkers monocyte chemoattractant protein-1 (MCP-1), soluble intercellular adhesion molecule-1 (sICAM-1), interleukin-1β (IL-1β), and granulocyte macrophage colony-stimulating factor (GM-CSF). In addition, we examined the expression of HMGB1 in the retinas of diabetic mice. Methods: Vitreous samples from 29 PDR and 17 nondiabetic patients were studied by enzyme-linked immunosorbent assay. Retinas of mice were examined by immunofluorescence analysis and western blotting. Results: HMGB1 was detected in all vitreous samples and sRAGE was detected in 5 PDR samples. IL-1β was detected in 3PDR samples and GM-CSF was not detected. Mean HMGB1 levels in PDR with active neovascularization were twofold and threefold higher than that in inactive PDR and nondiabetic patients, respectively. Mean HMGB1 levels in PDR patients with hemorrhage were significantly higher than those in PDR patients without hemorrhage and nondiabetic patients (p=0.0111). There were significant correlations between levels of HMGB1 and levels of MCP-1 (r=0.333, p=0.025) and sICAM-1 (r=0.548, p<0.001). HMGB1 expression was also upregulated in the retinas of diabetic mice. Conclusions: Subclinical chronic inflammation might contribute to the progression of PDR.

Original languageEnglish (US)
Pages (from-to)1829-1838
Number of pages10
JournalMolecular Vision
Volume17
StatePublished - Jul 29 2011

Fingerprint

Diabetic Retinopathy
Biomarkers
Inflammation
Retina
Chemokine CCL2
Intercellular Adhesion Molecule-1
Granulocyte-Macrophage Colony-Stimulating Factor
Interleukin-1
Hemorrhage
Fluorescent Antibody Technique
Western Blotting
Enzyme-Linked Immunosorbent Assay

ASJC Scopus subject areas

  • Ophthalmology

Cite this

El-Asrar, A. M. A., Nawaz, M. I., Kangave, D., Geboes, K., Ola, M. S., Ahmad, S., & Al-Shabrawey, M. (2011). High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. Molecular Vision, 17, 1829-1838.

High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. / El-Asrar, Ahmed M.Abu; Nawaz, Mohd Imtiaz; Kangave, Dustan; Geboes, Karel; Ola, Mohammad Shamsul; Ahmad, Saif; Al-Shabrawey, Mohamed.

In: Molecular Vision, Vol. 17, 29.07.2011, p. 1829-1838.

Research output: Contribution to journalArticle

El-Asrar AMA, Nawaz MI, Kangave D, Geboes K, Ola MS, Ahmad S et al. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. Molecular Vision. 2011 Jul 29;17:1829-1838.
El-Asrar, Ahmed M.Abu ; Nawaz, Mohd Imtiaz ; Kangave, Dustan ; Geboes, Karel ; Ola, Mohammad Shamsul ; Ahmad, Saif ; Al-Shabrawey, Mohamed. / High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. In: Molecular Vision. 2011 ; Vol. 17. pp. 1829-1838.
@article{138d7eefb77346deb8c75c8924cf3aa1,
title = "High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy",
abstract = "Purpose: To measure levels of high-mobility group box -1 (HMGB1) and soluble receptor for advanced glycation end products (sRAGE) in the vitreous fluid from patients with proliferative diabetic retinopathy (PDR) and to correlate their levels with clinical disease activity and the levels of the inflammatory biomarkers monocyte chemoattractant protein-1 (MCP-1), soluble intercellular adhesion molecule-1 (sICAM-1), interleukin-1β (IL-1β), and granulocyte macrophage colony-stimulating factor (GM-CSF). In addition, we examined the expression of HMGB1 in the retinas of diabetic mice. Methods: Vitreous samples from 29 PDR and 17 nondiabetic patients were studied by enzyme-linked immunosorbent assay. Retinas of mice were examined by immunofluorescence analysis and western blotting. Results: HMGB1 was detected in all vitreous samples and sRAGE was detected in 5 PDR samples. IL-1β was detected in 3PDR samples and GM-CSF was not detected. Mean HMGB1 levels in PDR with active neovascularization were twofold and threefold higher than that in inactive PDR and nondiabetic patients, respectively. Mean HMGB1 levels in PDR patients with hemorrhage were significantly higher than those in PDR patients without hemorrhage and nondiabetic patients (p=0.0111). There were significant correlations between levels of HMGB1 and levels of MCP-1 (r=0.333, p=0.025) and sICAM-1 (r=0.548, p<0.001). HMGB1 expression was also upregulated in the retinas of diabetic mice. Conclusions: Subclinical chronic inflammation might contribute to the progression of PDR.",
author = "El-Asrar, {Ahmed M.Abu} and Nawaz, {Mohd Imtiaz} and Dustan Kangave and Karel Geboes and Ola, {Mohammad Shamsul} and Saif Ahmad and Mohamed Al-Shabrawey",
year = "2011",
month = "7",
day = "29",
language = "English (US)",
volume = "17",
pages = "1829--1838",
journal = "Molecular Vision",
issn = "1090-0535",

}

TY - JOUR

T1 - High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy

AU - El-Asrar, Ahmed M.Abu

AU - Nawaz, Mohd Imtiaz

AU - Kangave, Dustan

AU - Geboes, Karel

AU - Ola, Mohammad Shamsul

AU - Ahmad, Saif

AU - Al-Shabrawey, Mohamed

PY - 2011/7/29

Y1 - 2011/7/29

N2 - Purpose: To measure levels of high-mobility group box -1 (HMGB1) and soluble receptor for advanced glycation end products (sRAGE) in the vitreous fluid from patients with proliferative diabetic retinopathy (PDR) and to correlate their levels with clinical disease activity and the levels of the inflammatory biomarkers monocyte chemoattractant protein-1 (MCP-1), soluble intercellular adhesion molecule-1 (sICAM-1), interleukin-1β (IL-1β), and granulocyte macrophage colony-stimulating factor (GM-CSF). In addition, we examined the expression of HMGB1 in the retinas of diabetic mice. Methods: Vitreous samples from 29 PDR and 17 nondiabetic patients were studied by enzyme-linked immunosorbent assay. Retinas of mice were examined by immunofluorescence analysis and western blotting. Results: HMGB1 was detected in all vitreous samples and sRAGE was detected in 5 PDR samples. IL-1β was detected in 3PDR samples and GM-CSF was not detected. Mean HMGB1 levels in PDR with active neovascularization were twofold and threefold higher than that in inactive PDR and nondiabetic patients, respectively. Mean HMGB1 levels in PDR patients with hemorrhage were significantly higher than those in PDR patients without hemorrhage and nondiabetic patients (p=0.0111). There were significant correlations between levels of HMGB1 and levels of MCP-1 (r=0.333, p=0.025) and sICAM-1 (r=0.548, p<0.001). HMGB1 expression was also upregulated in the retinas of diabetic mice. Conclusions: Subclinical chronic inflammation might contribute to the progression of PDR.

AB - Purpose: To measure levels of high-mobility group box -1 (HMGB1) and soluble receptor for advanced glycation end products (sRAGE) in the vitreous fluid from patients with proliferative diabetic retinopathy (PDR) and to correlate their levels with clinical disease activity and the levels of the inflammatory biomarkers monocyte chemoattractant protein-1 (MCP-1), soluble intercellular adhesion molecule-1 (sICAM-1), interleukin-1β (IL-1β), and granulocyte macrophage colony-stimulating factor (GM-CSF). In addition, we examined the expression of HMGB1 in the retinas of diabetic mice. Methods: Vitreous samples from 29 PDR and 17 nondiabetic patients were studied by enzyme-linked immunosorbent assay. Retinas of mice were examined by immunofluorescence analysis and western blotting. Results: HMGB1 was detected in all vitreous samples and sRAGE was detected in 5 PDR samples. IL-1β was detected in 3PDR samples and GM-CSF was not detected. Mean HMGB1 levels in PDR with active neovascularization were twofold and threefold higher than that in inactive PDR and nondiabetic patients, respectively. Mean HMGB1 levels in PDR patients with hemorrhage were significantly higher than those in PDR patients without hemorrhage and nondiabetic patients (p=0.0111). There were significant correlations between levels of HMGB1 and levels of MCP-1 (r=0.333, p=0.025) and sICAM-1 (r=0.548, p<0.001). HMGB1 expression was also upregulated in the retinas of diabetic mice. Conclusions: Subclinical chronic inflammation might contribute to the progression of PDR.

UR - http://www.scopus.com/inward/record.url?scp=79960729070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960729070&partnerID=8YFLogxK

M3 - Article

C2 - 21850157

AN - SCOPUS:79960729070

VL - 17

SP - 1829

EP - 1838

JO - Molecular Vision

JF - Molecular Vision

SN - 1090-0535

ER -